|
58
|
RFA-CE-18-000
RFA-CE-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-CK-18-000
RFA-CK-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-PS-18-000
RFA-PS-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-EH-18-000
RFA-EH-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-IP-18-000
RFA-IP-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-OE-18-000
RFA-OE-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-CD-18-000
RFA-CD-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-CC-18-000
RFA-CC-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-TP-18-000
RFA-TP-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-OT-18-000
RFA-OT-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
58
|
RFA-TS-18-000
RFA-TS-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-19 |
2030-09-30 |
1546 |
|
58
|
RFA-SH-18-000
RFA-SH-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-19 |
2030-09-30 |
1546 |
|
58
|
RFA-GH-18-000
RFA-GH-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-13 |
2030-09-30 |
1546 |
|
58
|
RFA-DD-18-000
RFA-DD-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
|
— |
2023-10-13 |
2030-09-30 |
1546 |
|
57
|
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
PAR-25-444 · National Institutes of Health · other
|
biomedical clinical
public health
agriculture food
|
— |
2025-11-26 |
2028-09-25 |
811 |
|
57
|
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-27-012 · National Institutes of Health · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2026-03-18 |
2028-11-02 |
849 |
|
53
|
RFA-DP-18-000
RFA-DP-18-000 · Centers for Disease Control and Prevention - ERA · other
|
public health
biomedical clinical
|
— |
2023-10-20 |
2030-09-30 |
1546 |
|
43
|
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
PAR-25-358 · National Institutes of Health · other
|
biomedical clinical
public health
ai data science
|
$150,000 |
2025-01-10 |
2028-01-07 |
549 |
|
43
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
PA-26-001 · National Institutes of Health · other
|
biomedical clinical
public health
ai data science
|
— |
2025-11-26 |
2028-11-30 |
877 |
|
33
|
Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
PAR-25-441 · National Institutes of Health · other
|
tribal indigenous
biomedical clinical
public health
|
— |
2025-08-26 |
2028-07-07 |
731 |
|
23
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
PA-24-253 · National Institutes of Health · other
|
biomedical clinical
|
— |
2024-07-11 |
2027-07-17 |
375 |
|
15
|
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
PAR-24-211 · National Institutes of Health · other
|
biomedical clinical
public health
|
— |
2024-07-15 |
2027-07-12 |
370 |
|
0
|
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
PA-24-254 · National Institutes of Health · other
|
biomedical clinical
public health
education workforce
|
— |
2024-07-11 |
2027-07-12 |
370 |